Help | RSS Feed

Medexus Pharmaceuticals Inc. (TSXV:MDP.V) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Medexus Pharmaceuticals Inc. (TSXV:MDP.V) seasonal charts above shows that a Buy Date of April 12 and a Sell Date of August 1 has resulted in a geometric average return of 11.62% above the benchmark rate of the S&P 500 Total Return Index over the past 8 years. This seasonal timeframe has shown positive results compared to the benchmark in 6 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 8 years by an average of 24.31% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 8 years of data is available for shares of MDP.V, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company. It is focused on auto-immune and pediatric diseases in the USA and Canada. The company’s only reportable segment being the products sold and the marketing services offered to the pharmaceutical industry. Geographically, it derives a majority of revenue from the United States. Its product portfolio includes Rasuvo, Metoject, Rupall, Gliolan, and Treosulfan.

To download MDP.V seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z